Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited
By BY PAM BELLUCK Health https://ift.tt/2TSOAUm Even those who supported the F.D.A.’s approval of the controversial new drug said authorizing it for anyone with Alzheimer’s disease was much too broad. New York Times your-feed-science, Alzheimer's Disease, Aduhelm (Drug), Drugs (Pharmaceuticals), Labeling and Labels (Product), Clinical Trials, your-feed-healthcare June 22, 2021 at 02:55AM